News on Glucose_Tolerance_Test from BioPortfolio.com http://www.BioPortfolio.com Consolidated Glucose_Tolerance_Test news from BioPortfolio.com Wed, 10 Feb 2010 04:46:20 GMT en LEP Business Fertiliser deal sends firm global A Lancashire biotech firm has signed a deal to double the globahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030404&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030404&THISHREF=http://c.moreover.com/click/here.pl%3fz2533601206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030404&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030404&THISHREF=http://c.moreover.com/click/here.pl%3fz2533601206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLancashire Evening Post: Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020056&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020056&THISHREF=http://c.moreover.com/click/here.pl%3fz2526574355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020056&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020056&THISHREF=http://c.moreover.com/click/here.pl%3fz2526574355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Citalopram Tevahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993541&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993541&THISHREF=http://c.moreover.com/click/here.pl%3fz2514650499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993541&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993541&THISHREF=http://c.moreover.com/click/here.pl%3fz2514650499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIrish Medical Times: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989181&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989181&THISHREF=http://c.moreover.com/click/here.pl%3fz2512051714%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989181&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989181&THISHREF=http://c.moreover.com/click/here.pl%3fz2512051714%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: GENFIT: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987271&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987271&THISHREF=http://c.moreover.com/click/here.pl%3fz2509741899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987271&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987271&THISHREF=http://c.moreover.com/click/here.pl%3fz2509741899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974560&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974560&THISHREF=http://c.moreover.com/click/here.pl%3fz2503590867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974560&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974560&THISHREF=http://c.moreover.com/click/here.pl%3fz2503590867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: The Submergence Tolerance Regulator Sub1A Mediates Stress-responsive Expression of AP2/ERF Transcription Factohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974351&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974351&THISHREF=http://c.moreover.com/click/here.pl%3fz2503432836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974351&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974351&THISHREF=http://c.moreover.com/click/here.pl%3fz2503432836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Tolerance: How AIRE wakes up sleepy geneshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958378&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958378&THISHREF=http://c.moreover.com/click/here.pl%3fz2495347621%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958378&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958378&THISHREF=http://c.moreover.com/click/here.pl%3fz2495347621%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNature: FuturaGene licenses its technology to Chinas BioCentury Transgene to develop GM cottonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957330&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957330&THISHREF=http://c.moreover.com/click/here.pl%3fz2494922828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957330&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957330&THISHREF=http://c.moreover.com/click/here.pl%3fz2494922828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProactive Investors.co.uk: Autonomic dysregulation and the Window of Tolerance model of the effects of complex emotional traumahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956244&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956244&THISHREF=http://c.moreover.com/click/here.pl%3fz2494452510%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956244&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956244&THISHREF=http://c.moreover.com/click/here.pl%3fz2494452510%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Vascular Inflammation in Patients with Impaired Glucose Tolerance and Type 2 Diabetes: Analysis with 18F-Fluorodeoxyglucose Positron Emission Tomographyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933752&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933752&THISHREF=http://c.moreover.com/click/here.pl%3fz2481902413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933752&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933752&THISHREF=http://c.moreover.com/click/here.pl%3fz2481902413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Enzyme Research: Data on enzyme research reported by researchers at Duke University, Division of Endocrinologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3917840&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3917840&THISHREF=http://c.moreover.com/click/here.pl%3fz2472484810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3917840&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3917840&THISHREF=http://c.moreover.com/click/here.pl%3fz2472484810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Intraocular Omni-focal Lens With Increased Tolerance to Decentration and Astigmatismhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911312&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911312&THISHREF=http://c.moreover.com/click/here.pl%3fz2469500197%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911312&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911312&THISHREF=http://c.moreover.com/click/here.pl%3fz2469500197%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOSN Super Site: Metformin treatment could prevent Type 2 diabetes for many Americanshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903098&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903098&THISHREF=http://c.moreover.com/click/here.pl%3fz2465006136%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903098&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903098&THISHREF=http://c.moreover.com/click/here.pl%3fz2465006136%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Tolerance Mechanisms in Pregnancy: A Reappraisal of the Role of Class I Paternal MHC Antigenshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899786&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899786&THISHREF=http://c.moreover.com/click/here.pl%3fz2463582328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899786&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Glucose_Tolerance_Test&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899786&THISHREF=http://c.moreover.com/click/here.pl%3fz2463582328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: